Sonictec, a leader in innovative healthcare solutions, today announced the approval and nationwide launch of Australia’s first 5-in-1 rapid test, a groundbreaking advancement designed to detect the five most common flu-like viruses—COVID-19, Influenza A, Influenza B, RSV, and Adenoviruses—using a single swab.
This all-in-one diagnostic tool empowers individuals to quickly identify the cause of their symptoms, enabling targeted treatment and informed decisions to curb community transmission.
A Game-Changer for Public Health
With winter approaching and respiratory illnesses on the rise, this test arrives at a pivotal moment. It simplifies the diagnostic process by eliminating the need for multiple tests or visits to healthcare facilities, offering rapid results within minutes. Key benefits include:
- Timely Diagnosis: Accurate identification of specific viruses in under 15 minutes.
- Reduced Healthcare Burden: Alleviates pressure on hospitals and clinics by enabling at-home testing.
- Informed Care: Helps individuals and families take virus-specific precautions, reducing further spread.
- Nationwide Accessibility: Available at major pharmacies across Australia starting late April 2025.
Frank Fan, Product R&D Director at Sonictec, emphasised the test’s transformative potential:“This innovation marks a new era in managing seasonal illnesses.
“By pinpointing the exact virus, Australians can protect their loved ones more effectively and make smarter health choices. It’s not just a test—it’s a critical tool for community well-being.” said Fan
Addressing Seasonal Health Challenges
Recent Trends in Respiratory Viruses
Over the past three years, Australia has faced overlapping waves of respiratory illnesses, driven by the co-circulation of COVID-19, influenza, RSV, and Adenoviruses.
COVID-19 continues to evolve, with newer variants causing milder symptoms but maintaining high transmissibility. Meanwhile, Adenoviruses—often overlooked—have been linked to outbreaks of conjunctivitis and gastroenteritis, particularly in schools and aged-care facilities.
Symptom Overlap and Diagnostic Challenges
The similarity of symptoms—fever, cough, fatigue—across these viruses has complicated clinical diagnoses. For example:
- COVID-19: Unique markers include loss of taste/smell and prolonged fatigue.
- RSV: Severe wheezing in infants and the elderly.
- Adenovirus: Red eyes (conjunctivitis) and gastrointestinal distress.
Misdiagnosis often leads to delayed care or unnecessary antibiotic prescriptions, exacerbating antimicrobial resistance.
The Role of Rapid Testing in Mitigating Outbreaks
The Sonictec 5-in-1 test addresses these challenges head-on. Early identification via rapid tests could reduce such outcomes by enabling timely antiviral treatments (e.g., Tamiflu for influenza) or isolation protocols for COVID-19.
Impact on Vulnerable Populations
- Children: RSV remains the leading cause of hospitalization in infants.
- Elderly: Flu-related cardiovascular complications rise sharply in those over 65.
- Immunocompromised: Adenovirus infections can escalate into severe pneumonia.
By empowering households to test early, the 5-in-1 kit helps protect these groups before severe symptoms develop.
Availability and Support
The Sonictec 5-in-1 Rapid Test will be available for purchase at pharmacies nationwide by late April 2025. Health experts urge Australians to stock the test ahead of winter, when respiratory viruses typically peak.
Public Health Specialist Dr. Emily Harris, says the convergence of COVID-19, flu, and RSV has created a ‘tripledemic’ threat. Tools like Sonictec’s test are vital to breaking the cycle and safeguarding our communities.
About Sonictec
Sonictec is an Australian healthcare innovator dedicated to developing accessible,
cutting-edge diagnostic tools. Committed to improving public health outcomes, the
company focuses on solutions that empower individuals and communities to take
control of their well-being.
